Screener
Harmony Biosciences Holdings, Inc. HRMY Q3 2025 earnings
Reported November 4, 2025 · Before market open
Revenue$239.5MMiss by $581.2K
EPS$0.87Miss by $0.05
Revenue estimate$240.0M
EPS estimate$0.92
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$274.5M
EPS estimate$1.11
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Harmony Biosciences Holdings, Inc. report Q3 2025 earnings?
- Harmony Biosciences Holdings, Inc. (HRMY) reported Q3 2025 earnings on November 4, 2025 before market open.
- What were Harmony Biosciences Holdings, Inc.'s Q3 2025 revenue and EPS?
- Harmony Biosciences Holdings, Inc. reported revenue of $239.5M and eps of $0.87 for Q3 2025.
- Did Harmony Biosciences Holdings, Inc. beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $240.0M by $581.2K. EPS missed the consensus estimate of $0.92 by $0.05.
- How did Harmony Biosciences Holdings, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 28.7% from $186.0M a year earlier and eps grew 10.1% from $0.79.
- Where can I find Harmony Biosciences Holdings, Inc.'s Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001104659-25-105942) and the 10-Q periodic report (0001104659-25-105962) directly on SEC EDGAR. The filing index links above go to sec.gov.
